Pim Aarts

Pim Aarts is affiliated with the Department of Dermatology at Erasmus MC, part of Erasmus University Rotterdam. His research focuses on advanced treatments for skin disorders, particularly Hidradenitis Suppurativa and keloid management. He has conducted pivotal studies on drug efficacy, including adalimumab and bleomycin therapies, and pioneered needle-free jet injector technologies for dermatological applications.

Key research outputs include a 2024 doctoral thesis on optimizing Hidradenitis Suppurativa therapies and randomized controlled trials evaluating novel treatment modalities. His work bridges clinical practice and medical innovation, addressing both common and rare dermatological conditions.

Collaborations span international dermatology networks, with recent focuses on drug delivery systems and combination therapies. His studies emphasize evidence-based approaches to chronic skin diseases, contributing to improved patient outcomes through innovative interventions.